These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4718546)

  • 1. [Factor of capillary permeability in lymphocyte culture supernatant in nephrotic syndromes. Preliminary results].
    Lagrue G; Xhenemont S; Branellec A
    Nouv Presse Med; 1973 Jun; 2(25):1719. PubMed ID: 4718546
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vascular permeability factor in the supernatant of lymphocyte cultures in subjects with nephrotic syndrome].
    Lagrue G; Branellec A; Xheneumont S; Hanbec G; Weil B
    J Urol Nephrol (Paris); 1975; 81(4-5):344-8. PubMed ID: 1099228
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular permeability factor produced by lymphocytes of patients with nephrotic syndrome.
    Sobel A; Heslan JM; Branellec A; Lagrue G
    Adv Nephrol Necker Hosp; 1981; 10():315-32. PubMed ID: 6791474
    [No Abstract]   [Full Text] [Related]  

  • 4. A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome.
    Lagrue G; Xheneumont S; Branellec A; Hirbec G; Weil B
    Biomedicine; 1975 Feb; 23(1):37-40. PubMed ID: 1174637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokine 'skin reactive factor' (SRF) and the nephrotic syndrome.
    Lagrue G; Branellec A; Xheneumont S; Weil B
    Bibl Anat; 1975; 13():331-4. PubMed ID: 1231773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular permeability factor and nephrotic syndrome.
    Trompeter RS; Barratt TM; Layward L
    Lancet; 1978 Oct; 2(8095):900. PubMed ID: 81452
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of a lymphokine acting upon vascular permeability. Initial application in renal pathology].
    Lagrue G; Sobel A; Branellec A; Blanc C
    Ann Med Interne (Paris); 1978 Jan; 129(1):57-60. PubMed ID: 637461
    [No Abstract]   [Full Text] [Related]  

  • 8. [The glomerular permeability factor].
    Birmelé B; Girardin E; Nivet H
    Nephrologie; 2001; 22(3):99-103. PubMed ID: 11436670
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Lymphokines and nephrotic syndrome.
    Lagrue G; Xheneumont S; Branellec A; Weil B
    Lancet; 1975 Feb; 1(7901):271-2. PubMed ID: 46408
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular mechanism of edema formation in nephrotic syndrome].
    Deschênes G; Guigonis V; Doucet A
    Arch Pediatr; 2004 Sep; 11(9):1084-94. PubMed ID: 15351000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties.
    Lagrue G; Branellec A; Blanc C; Xheneumont S; Beaudoux F; Sobel A; Weil B
    Biomedicine; 1975 Feb; 23(2):73-5. PubMed ID: 168931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications.
    Doucet A; Favre G; Deschênes G
    Pediatr Nephrol; 2007 Dec; 22(12):1983-90. PubMed ID: 17554565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A cell culture model in vitro for studying the permeability of cochlear microvascular endothelial cells in guinea pigs].
    Zhang X; Wei Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):409-11. PubMed ID: 12761951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of nephrotic syndrome].
    Djukanović LJ
    Srp Arh Celok Lek; 1996; 124 Suppl 1():70-4. PubMed ID: 9102937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome.
    Ishikura K; Ikeda M; Hamasaki Y; Hataya H; Nishimura G; Hiramoto R; Honda M
    Nephrol Dial Transplant; 2008 Aug; 23(8):2531-6. PubMed ID: 18258739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New findings on the pathogenesis of nephrotic syndrome (review article)].
    Tesar V; Zima T; Kalousová M
    Sb Lek; 2002; 103(3):379-95. PubMed ID: 12688182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.
    Matsumoto K; Kanmatsuse K
    Clin Nephrol; 1999 Jul; 52(1):10-8. PubMed ID: 10442490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glomerular capillary and disease.
    Michael AF; Nevins T; Fish A; Scheinman J
    Aust N Z J Med; 1981; 11(Suppl 1):76-82. PubMed ID: 7020670
    [No Abstract]   [Full Text] [Related]  

  • 19. Production of a suppressor factor by adherent cells from Mycobacterium tuberculosis-infected guinea-pigs.
    Wadee AA; Rabson AR
    Clin Exp Immunol; 1981 Aug; 45(2):427-32. PubMed ID: 6459198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients.
    Boulton Jones JM; Tulloch I; Dore B; McLay A
    Clin Nephrol; 1983 Aug; 20(2):72-7. PubMed ID: 6352108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.